Home > Annual Financials > NURECA

NURECA Financial Statement Analysis
[BOM: 543264|NSE : NURECA]

The Revenues of NURECA have decreased by -56.44% YoY .
The Earnings Per Share (EPS) of NURECA has decreased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

NURECA Last 5 Annual Financial Results
[BOM: 543264|NSE : NURECA]

ConsolidatedMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹111 Cr₹256 Cr₹213 Cr₹99 Cr₹62 Cr
Expenses ₹126 Cr₹200 Cr₹152 Cr₹90 Cr₹53 Cr
Operating Profit (Excl OI) ₹-15 Cr₹56 Cr₹62 Cr₹9.69 Cr₹9.06 Cr
Other Income ₹7.11 Cr₹7.70 Cr₹2.82 Cr₹0.06 Cr₹0.09 Cr
Interest ₹0.45 Cr₹0.74 Cr₹1.60 Cr₹0.77 Cr₹0.24 Cr
Depreciation ₹2.39 Cr₹1.48 Cr₹0.42 Cr₹0.37 Cr₹0.06 Cr
Profit Before Tax ₹-11 Cr₹61 Cr₹62 Cr₹8.61 Cr₹8.84 Cr
Profit After Tax ₹-8.25 Cr₹45 Cr₹46 Cr₹6.40 Cr₹6.23 Cr
Consolidated Net Profit ₹-8.25 Cr₹45 Cr₹46 Cr₹6.40 Cr₹6.23 Cr
Earnings Per Share (Rs)₹-8.25₹44.96₹46.37₹6,395.00₹6,226.00
PAT Margin (%)-7.0816.6420.626.439.77
ROE(%)-4.1424.5552.3961.23162.03
ROCE(%)-5.1733.5767.6156.70179.97
Total Debt/Equity(x)0.000.000.010.700.06

Key Financials

Market Cap : ₹ 255.2 Cr
Revenue (TTM) : ₹ 96.2 Cr
Net Profit(TTM) : ₹ 0.8 Cr
EPS (TTM) : ₹ 0.8
P/E (TTM) : 310.4

Industry Peers & Returns1W1M1Y
NURECA -5.6% -18.7% -6.7%
POLY MEDICURE 5.1% -3.2% 67.7%
PREVEST DENPRO -0.7% -13.2% 24.9%


NURECA Revenues
[BOM: 543264|NSE : NURECA]

Y-o-Y

-56.44 %

5 Yr CAGR

15.81 %

Years Revenues % Change
Mar2023 ₹111 Cr
-56.44
Mar2022 ₹256 Cr
19.72
Mar2021 ₹213 Cr
114.69
Mar2020 ₹99 Cr
60.63
Mar2019 ₹62 Cr -


NURECA Operating Profit
[BOM: 543264|NSE : NURECA]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Profit % Change
Mar2023 ₹-15 Cr
Negative
Mar2022 ₹56 Cr
-9.80
Mar2021 ₹62 Cr
534.84
Mar2020 ₹9.69 Cr
7.06
Mar2019 ₹9.06 Cr -

Operating Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Margin% % Change
Mar2023 -13.48%
Negative
Mar2022 21.72%
-24.66
Mar2021 28.83%
195.69
Mar2020 9.75%
-33.36
Mar2019 14.63% -

NURECA Profit After Tax
[BOM: 543264|NSE : NURECA]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2023 ₹-8.25 Cr
Negative
Mar2022 ₹45 Cr
-3.05
Mar2021 ₹46 Cr
625.16
Mar2020 ₹6.40 Cr
2.71
Mar2019 ₹6.23 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2023 -7.08 %
Negative
Mar2022 16.64 %
-19.30
Mar2021 20.62 %
220.68
Mar2020 6.43 %
-34.19
Mar2019 9.77 % -

NURECA Earnings Per Share (EPS)
[BOM: 543264|NSE : NURECA]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2023 ₹-8.25
Negative
Mar2022 ₹45
-3.04
Mar2021 ₹46
-99.27
Mar2020 ₹6,395
2.71
Mar2019 ₹6,226 -

NURECA Return on Capital Employed (ROCE)
[BOM: 543264|NSE : NURECA]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years ROCE % Change
Mar2023 -5.17%
Negative
Mar2022 33.57%
-50.35
Mar2021 67.61%
19.24
Mar2020 56.7%
-68.49
Mar2019 179.97% -

NURECA Share Price vs Sensex

Current Share Price : ₹255.2
Current MarketCap: ₹ 255.2 Cr
Updated EOD on :Mar 28,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
NURECA

-5.6%

-18.7%

-6.7%

SENSEX

-0.4%

-0.9%

25.8%

NURECA related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about NURECA Financials


How the annual revenues of NURECA have changed ?

The Revenues of NURECA have decreased by -56.44% YoY .

How the Earnings per Share (EPS) of NURECA have changed?

The Earnings Per Share (EPS) of NURECA has decreased by Negative YoY .


Compare Stock Analytics of Peers of NURECA
POLY MEDICURE LTD vs PREVEST DENPRO LTD vs NURECA LTD